Search results
Results from the WOW.Com Content Network
Continuation of alcohol use will result in a higher risk of progression of liver disease and cirrhosis. In patients with acute alcoholic hepatitis, clinical manifestations include fever, jaundice, hepatomegaly, and possible hepatic decompensation with hepatic encephalopathy, variceal bleeding, and ascites accumulation. Tender hepatomegaly may ...
Alcohol withdrawal syndrome (AWS) is a set of symptoms that can occur following a reduction in or cessation of alcohol use after a period of excessive use. [1] Symptoms typically include anxiety , shakiness , sweating, vomiting, fast heart rate , and a mild fever. [ 1 ]
The Mayo Clinic diet is a diet plan formulated by the doctors of Mayo Clinic, which outlines two different phases: lose it and live it. Everything you need to know about the Mayo Clinic diet Skip ...
Fetal alcohol syndrome (FAS) [1] Partial fetal alcohol syndrome (pFAS) refers to individuals with a known, or highly suspected, history of prenatal alcohol exposure who have alcohol-related physical and neurodevelopmental deficits that do not meet the full criteria for FAS. [22] Alcohol-related neurodevelopmental disorder (ARND) [22] [1]
The Mayo Clinic diet has two phases during which you can lose up to 10 pounds in two weeks. Here's what to know about it, including the Mayo Clinic Diet menu.
The Mayo Clinic Diet eating plan is low in fat and calories and prioritizes whole grains, fruits and vegetables. The diet also has two phases lasting 12 weeks, with the option to continue for as ...
Korsakoff's syndrome and Wernicke–Korsakoff syndrome are particular forms of alcohol related brain injury which may be related to alcohol related dementia. [18] Many experts use the terms alcohol (or alcoholic) dementia to describe a specific form of ARD, characterized by impaired executive function (planning, thinking, and judgment). [5]
Marchiafava–Bignami disease (MBD) is a progressive neurological disease of alcohol use disorder, characterized by corpus callosum demyelination and necrosis and subsequent atrophy. The disease was first described in 1903 by the Italian pathologists Amico Bignami and Ettore Marchiafava in an Italian Chianti drinker.